Prof. Dr. Jürgen K. Rockstroh
International HIV physician, viral hepatitis researcher, and guideline leader reviewing patient-facing HIV and HCV content for clinical accuracy and evidence integrity.
A Senior HIV Physician Reviewing Patient-Facing HIV and HCV Content
Prof. Dr. Jürgen K. Rockstroh is Professor of Medicine and Head of the HIV Outpatient Clinic at the University of Bonn / University Hospital Bonn in Germany. His public institutional profiles identify him as a long-standing HIV clinician and researcher with major work in antiretroviral therapy, HIV disease in haemophiliacs, and HIV with viral hepatitis co-infection.
His HIV and hepatitis work is unusually relevant for SunnyPharma® because much of the site’s medical education covers antiretroviral therapy, access barriers, medication cost questions, generic ARV formulations, PrEP/PEP, and hepatitis C direct-acting antiviral treatment. Rockstroh’s clinical and academic record directly overlaps with HIV treatment, hepatitis C, HBV/HCV screening, co-infection management, and guideline-based infectious disease care.
As Medical Editor for SunnyPharma®, Prof. Rockstroh reviews patient-facing content for medical accuracy, guideline alignment, source quality, and clear separation between evidence, clinical interpretation, and access-related commentary. His role is editorial review and medical oversight; SunnyPharma® content remains educational and does not replace individualized care from a licensed clinician.
For HIV and hepatitis content, credibility depends on saying exactly what the evidence supports — no more, no less. Patients deserve accuracy, context, and a clear distinction between medical facts and access decisions.
Peer-Reviewed HIV and Hepatitis C Publications
Prof. Rockstroh has authored and co-authored extensive peer-reviewed literature on HIV treatment, viral hepatitis, and HIV/HCV co-infection. Representative works include:
Leadership, Guideline and Public Health Contributions
Prof. Rockstroh’s professional profile includes HIV clinical leadership, guideline involvement, hepatitis co-infection expertise, and European HIV testing policy work. Representative public verification points:
-
Professor of Medicine and Head of the HIV Outpatient Clinic at the University of Bonn
-
European AIDS Clinical Society leadership, including EACS guideline panel activity and EACS presidency
-
International AIDS Society governing council service
-
Research focus on antiretroviral therapy, HIV disease in haemophiliacs, and HIV/hepatitis co-infection
-
Recipient of the Federal Cross of Merit awarded by the Federal Republic of Germany
How Prof. Rockstroh Reviews SunnyPharma® Content
Every article assigned for medical review is checked against three reference layers in sequence: (1) current FDA-approved or EMA-authorized prescribing information where applicable, (2) current HIV and viral hepatitis guideline statements from recognized authorities including DHHS/NIH, EACS, IAS-USA, AASLD/IDSA, WHO, and EASL, and (3) peer-reviewed literature on clinical efficacy, drug resistance, adherence, safety, co-infection, real-world outcomes, and treatment-experienced populations.
Conflict of interest disclosure. Prof. Rockstroh is a major HIV and viral hepatitis academic whose conference and publication disclosures should be reviewed and updated before publication. Historical public disclosures include consultancy and speaker relationships with HIV/HCV pharmaceutical manufacturers. SunnyPharma® should obtain a current written COI declaration before listing him as an active Medical Editor.
Independence boundary. SunnyPharma® is an independent health education platform — not a pharmacy, not a seller, and not affiliated with any pharmaceutical manufacturer. Prof. Rockstroh’s university and clinical roles are separate from any SunnyPharma® editorial review work. No SunnyPharma® content is directed to patients under his direct clinical care.